What Is the Mounjaro Price Now, and What Should It Include?

Why has the Mounjaro price changed so much recently?

Eli Lilly sets a list price for Mounjaro in the UK, and in September 2025 that price rose sharply at the higher doses. The highest-dose pen's list price increased from around £122 to roughly £330, as widely reported at the time. Private providers price above that list cost to cover dispensing, clinical review and operating overhead, which is why the market now sits broadly in the £149–£375 range per four-week pen depending on dose and provider. Lower doses remain less expensive; if you want to understand exactly what the 5 mg pen costs before moving further up the dose ladder, our breakdown of the Mounjaro 5 mg price covers what to expect at that stage. The starting pen (2.5mg, which exists to let your system adjust rather than to drive weight loss) sits at the lower end of that range.

If you want a closer look at how specific doses are priced, our guide to Mounjaro pricing in the UK covers how the dose ladder affects cost month by month. The short version: as your prescriber titrates you upward over time, the monthly cost moves with the dose. That is normal and expected, but worth planning for from the start.

These figures are hedged for a reason. Prices move, and if you are trying to understand why your quote looks higher than it did a few months ago, our page explaining why the Mounjaro price has gone up sets out the background in detail. Current Mounjaro cost information is best confirmed directly with any pharmacy you are considering, ideally in writing so there are no surprises.

What do some Mounjaro price quotes actually leave out?

A headline monthly price for a prescription medicine can mean almost anything. Some providers quote the pen cost alone and charge separately for the initial consultation, the prescription fee, delivery and any follow-up clinical review. Those extras can add £30–£60 or more on top of what looked like a straightforward number. Some charge for dose-increase reviews; others lock you into a subscription that auto-renews even if your circumstances change.

Aftercare is the piece most commonly missing. Mounjaro is titrated, your dose is expected to increase over time, and questions come up along the way. If support between orders costs extra, or if reaching someone requires a premium phone line, that shapes the real cost of treatment over six months far more than a £10 difference in the pen price. For a fuller breakdown of what to look for when comparing Mounjaro prices across providers, the dose, service and aftercare access are the variables that matter most.

NICE's appraisal of tirzepatide, TA1026, makes clear that Mounjaro is intended to be used alongside a reduced-calorie diet, increased physical activity and ongoing clinical support, not as a standalone prescription. Providers who include that support in one price are delivering what the treatment is designed to sit within.

Where does nume sit on price, and why?

Plainly: cheapest is not a race we entered. Our price is deliberately set to cover everything, free consultation, same-day review by a named GPhC-registered prescriber (not a bot), the medicine itself, free next-working-day tracked delivery by DPD in unmarked packaging, and seven-day aftercare with no extra charges. There is no subscription. Every repeat order is reviewed clinically before it goes out. You can see exactly what treatment costs on our treatment page, and that figure does not change at checkout.

We are transparent about this because it is a trade-off worth naming. If your sole criterion is the lowest advertised number, we will probably lose that comparison. What you get in exchange is a prescriber who reads your consultation on the day you submit it, a question our clinical team fields most weeks is from people who switched after an experience where no one seemed to actually review their case. Our clinical lead's profile is there if you want to see who oversees that process. One fixed price. No hidden steps.

Is 'cheapest' even the right measure for a prescription medicine?

For most purchases, price is a reasonable shortcut for value. For a prescription-only medicine dispensed from a UK pharmacy, it is the wrong test. The MHRA has warned publicly about counterfeit weight-loss pens sold online and via social media, fake pens have contained insulin and caused hospitalisations, and in October 2025 enforcement teams raided the first illicit UK manufacturing site producing counterfeit tirzepatide pens. Around 20 million doses of illegally traded weight-loss medicines, with an estimated street value of roughly £45 million, were seized in 2025 alone. The MHRA's Yellow Card scheme allows anyone to report suspect sellers.

The marker of a legitimate supply is not price, it is a pharmacy you can verify on the GPhC register. Any seller offering Mounjaro without a clinical assessment, at prices far below the market, or via social media with a discount code attached, is a red flag. A discount code for a prescription medicine from an unverified source answers the wrong question entirely. The right question is whether the supply is genuine, the clinical review is real, and the aftercare is there if you need it. If you want to explore whether treatment is right for you, speaking to our prescribers is the place to start.